A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
Clinical trial NCT00053638 · COMPLETED
Trial details
- NCT number
- NCT00053638
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-02-01
- Primary completion
- 2004-10-01
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.